Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 25, 2026
TickeronGET DAILY SIGNALS
Northrop Grumman (NOC): Strong Backlog Supports 5%–7% Growth Outlook

Northrop Grumman (NOC): Strong Backlog Supports 5%–7% Growth Outlook

Key Takeaways

  • Upcoming catalyst: Management has issued initial 2027 guidance for 5%–7% sales growth and further acceleration in 2028, backed by a record $109.6 billion backlog that provides multi-year revenue visibility.
  • Strategic positioning: Northrop Grumman sits at the center of high-priority defense categories — including the B-21 Raider bomber, the Sentinel intercontinental ballistic missile (ICBM), F-35 components, and national security space — aligning it closely with U.S. and allied modernization priorities.
  • Industry tailwind: Rising U.S. and international defense budgets and heightened geopolitical tensions are supporting strong bookings, with the company reporting a quarterly book-to-bill ratio (new orders divided by billed revenue) of 1.5.
  • Macro sensitivity: Revenue depends heavily on U.S. government appropriations, so continuing resolutions, budget timing, and defense supplemental packages remain key swing factors for the growth trajectory.
  • Analyst sentiment: Consensus leans toward "Buy," with a widely cited average price target of roughly $631, though estimates range widely from about $430 to $815 — reflecting genuine disagreement over execution risk and margin durability.
  • Key risk: Fixed-price development contracts, particularly on B-21 and certain missile programs, carry execution risk that has periodically triggered estimate-at-completion (EAC) charges and margin pressure.

Northrop Grumman's Strategic Positioning

Northrop Grumman is one of the largest U.S. aerospace and defense prime contractors, with a portfolio spanning aeronautics systems, mission systems, defense systems, and space systems. Its competitive edge rests on long-cycle, technically complex programs that are difficult for rivals to replicate — most notably the B-21 Raider stealth bomber and the Sentinel ICBM, both of which provide franchise-like revenue visibility extending well beyond the current decade.

A record backlog of roughly $109.6 billion — equivalent to more than two years of annual revenue — is the core of the company's medium-term positioning. Management expects about 35% of that backlog to convert to revenue over the next 12 months and a further 55% over the following 24 months, giving investors an unusually durable line of sight. At the same time, Northrop is deliberately shifting its mix away from lower-margin development work toward higher-margin production as programs mature, a transition executives believe will reduce margin volatility over time. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Structurally, the company remains heavily concentrated with the U.S. government, which accounts for roughly 84% of sales. To diversify, management has set a goal of doubling international revenue to $10 billion by 2031, leveraging platforms such as the IBCS (Integrated Battle Command System) air-and-missile-defense network and Triton surveillance aircraft.

Key Catalysts on the Horizon

Several developments could shape investor sentiment over the coming quarters. First, the company has guided to 5%–7% sales growth in 2027 with 10–20 basis points of segment operating margin expansion and adjusted free cash flow of $3.3 billion–$3.7 billion. Delivering on that framework would reinforce confidence in the multi-year growth story.

Second, program milestones matter. The first integrated flight of the Sentinel missile is expected in 2027, and B-21 production capacity investments are slated to continue through 2028 before translating into higher output. Progress on these programs — or any new EAC charge — could move the stock in either direction.

Third, the fiscal 2027 U.S. budget process, including potential supplemental defense funding and a reconciliation package focused on military modernization, will influence award timing and the pace of new bookings. Finally, analyst actions have become more constructive: Baird recently upgraded the stock to Outperform with a $675 price target, while several firms — including Citi, UBS, and Deutsche Bank — have raised or reaffirmed Buy ratings. The consensus recommendation is "Buy," with an average price target near $631, though a minority of analysts, such as Barclays with a $430 target, remain notably cautious.

Industry and Macroeconomic Influences

Northrop Grumman's trajectory is closely tied to geopolitical and fiscal policy rather than conventional consumer cycles. Heightened global tensions are driving increased defense investment across the U.S. and its allies, and proposals to raise U.S. military spending toward approximately $1.5 trillion by 2027 underscore the scale of the opportunity — if fully appropriated by Congress.

Interest rates and inflation exert a secondary influence: higher rates raise the cost of capital and can weigh on valuation multiples for defense stocks, while cost inflation in labor and materials pressures margins on fixed-price contracts. The company's capital-expenditure-heavy ramp — roughly $2.1 billion planned for 2027 — reflects both capacity expansion and a bet on sustained demand. Regulatory and supply-chain dynamics, including skilled-labor shortages across aerospace, remain persistent operational headwinds that could affect delivery schedules and profitability.

2026 Outlook and Longer-Term Themes

For 2026, Northrop Grumman has raised its adjusted EPS (earnings per share) outlook to $29.35–$29.75, with sales of $43.75 billion–$44.25 billion and adjusted free cash flow of $3.1 billion–$3.5 billion. Looking beyond, the structural story hinges on several long-term themes: the continued ramp of B-21 and Sentinel, the expansion of national security space (where backlog now exceeds $16 billion), and the shift from development to production that management expects to lift margins.

Emerging opportunities — including the F/A-XX next-generation fighter, collaborative combat aircraft, solid rocket motor capacity expansion, and the FORTITUDE microelectronics and quantum computing initiatives — could open commercial-adjacent and higher-growth markets. Competitive and execution risks remain the principal counterweights: fixed-price development programs, budget appropriations, and supply-chain constraints could all alter the trajectory. Consensus expectations currently reflect cautious optimism, with growth acceleration into 2027 and 2028 viewed as the central scenario rather than a certainty.

Exploring AI Tools in My Research Process

In my analysis of defense names like NOC, I have found value in supplementing fundamental work with data-driven signals. Tickeron's Trend Prediction Engine stands out as a practical way to gauge near-term momentum and potential shifts in investor sentiment across a wide range of assets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NOC

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


Aroon Indicator for NOC shows an upward move is likely

NOC's Aroon Indicator triggered a bullish signal on November 10, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 234 similar instances where the Aroon Indicator showed a similar pattern. In 147 of the 234 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 17, 2026. You may want to consider a long position or call options on NOC as a result. In 44 of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.

NOC moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NOC crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.

Following a +2.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOC advanced for three days, in 196 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

Bearish Trend Analysis

The 10-day RSI Indicator for NOC moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 21 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for NOC turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 28 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

NOC broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. NOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.170) is normal, around the industry mean (5.050). P/E Ratio (16.656) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (3.350) is also within normal values, averaging (3.110). Dividend Yield (0.019) settles around the average of (0.055) among similar stocks. P/S Ratio (1.766) is also within normal values, averaging (18.367).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 36.83B. The market cap for tickers in the group ranges from 4.49 to 1.77T. SPCX holds the highest valuation in this group at 1.77T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -12%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was -32%. HAWK experienced the highest price growth at 20%, while SPCE experienced the biggest fall at -58%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 8%. For the same stocks of the Industry, the average monthly volume growth was 40% and the average quarterly volume growth was -44%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 54
Price Growth Rating: 63
SMR Rating: 78
Profit Risk Rating: 78
Seasonality Score: -10 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of innovative systems, products and solutions in aerospace, electronics and information systems

Industry AerospaceDefense

Industry
Aerospace And Defense
Address
2980 Fairview Park Drive
Phone
+1 703 280-2900
Employees
95000
Web
https://www.northropgrumman.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.